$KLRS 3 SEC Filings

Filed On	Filing
03 Aug 2026	Form 3: Keating Laurie, Director No securities owned
27 Jul 2026	Form 3: Vandekop Amy O'Leary, See Remarks Holds 948 shares of Common Stock
20 Jul 2026	Form 3: Bayko Liisa Ann, Chief Financial Officer No securities owned
03 Nov 2025	Form 3: Gall Matthew, Chief Financial Officer No securities owned
04 Apr 2025	Form 3: Patterson Leone D, Director No securities owned
25 Mar 2025	Form 3: Samsara BioCapital GP, Llc, 10% owner and 1 other Holds 11,448,081 shares of Common Stock
18 Mar 2025	Form 3: Akkaraju Srinivas, Director No securities owned
18 Mar 2025	Form 3: Dybbs Michael, Director No securities owned
18 Mar 2025	Form 3: Ferrara Napoleone, Director No securities owned
18 Mar 2025	Form 3: Patel Samir Chandrakant, Director No securities owned
18 Mar 2025	Form 3: Oxtoby Andrew, Director No securities owned
18 Mar 2025	Form 3: Feinsod Matthew, Chief Medical Officer No securities owned
18 Mar 2025	Form 3: Adamis Anthony P, Director No securities owned
21 Jun 2023	Form 3: Piccina Cintia, Chief Commercial Officer No securities owned
03 Mar 2023	Form 3: Adams Derek N., Director No securities owned
05 Aug 2022	Form 3: Gilead SCIENCES, Inc., 10% owner Holds 13,704,416 shares of Common Stock
05 Aug 2022	Form 3: F2 Mg Ltd, Director and 6 others Holds 2,059,884 shares of Common Stock
31 Mar 2022	Form 3: Tomasello Shawn, Director No securities owned
30 Jul 2020	Form 3: Hagen Brett R, Chief Accounting Officer Holds 49,815 shares of Common Stock
30 Jul 2020	Form 3: Sinha Vikas, Director Holds 806,607 shares of Common Stock

Comments